The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 265.00
Bid: 260.00
Ask: 270.00
Change: 0.00 (0.00%)
Spread: 10.00 (3.846%)
Open: 265.00
High: 265.00
Low: 265.00
Prev. Close: 265.00
CRPR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of equity and director dealings

13 Nov 2014 07:00

RNS Number : 8996W
Cropper(James) PLC
13 November 2014
 



13 November 2014

 

James Cropper plc (the 'Company')

 

Issue of equity and director dealings

 

 

Issue of equity

 

The Company announces that 187,614 new ordinary shares of 25p each in the Company ("Shares") were issued and allotted on 12 November 2014 pursuant to the exercise of options by employees of the Company.

 

Application has been made to the London Stock Exchange for the Shares to be admitted to trading on AIM ("Admission"), and it is expected that Admission will become effective and trading will commence at 8.00am on 18 November 2014.

Following Admission of the Shares, the Company's enlarged issued share capital will comprise of 9,161,656 Shares with voting rights. The Company does not hold any Shares in treasury. Therefore the total number of Shares in the Company with voting rights will be 9,161,656. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

Director dealings

 

Exercise of options

The Company was notified on 12 November 2014 that, as part of the exercise of options referred to above, Martin Thompson, a director of the Company, had on that day exercised options over 18,251 Shares at a price of 85.2 pence per Share.

 

Following the exercise of options, Martin Thompson has a beneficial holding of 40,193 Shares, representing 0.44% of the Company's issued share capital (following Admission).

 

Acquisition of Shares by the James Cropper Employee Benefit Trust Ltd

In addition, the Company announces that it was notified on 12 November 2014 that the James Cropper Employee Benefit Trust Ltd (the "James Cropper EBT") had on that day acquired 41,255 Shares at a price of 405 pence per Share. This was to satisfy future releases under the James Cropper plc 2008 Long Term Incentive Scheme Plan in which the participants, including executive directors, have a potential interest subject to the achievement of performance targets. 

 

Following the transaction, the James Cropper EBT is interested in 101,255 Shares, representing 1.11 per cent. of the issued share capital of the Company.

 

The Directors of the Company who are also directors of the James Cropper EBT together with their beneficial and non-beneficial interests in the Company are as follows:

 

 

Number of Shares

Percentage of issued share capital (following Admission)

Mark Cropper

Beneficial

1,206,540

13.17

Non-beneficial

129,339

1.41

Douglas Mitchell

Beneficial

1,000

0.01

Non-beneficial

101,255

1.11

Jim Sharp

Beneficial

7,950

0.09

Non-beneficial

101,255

1.11

David Wilks

Beneficial

9,112

0.10

Non-beneficial

101,255

1.11

 

 

 

Enquiries:

Isabelle Maddock, Group Finance Director

Robert Finlay/Nick Ellis

James Cropper PLC

Westhouse Securities Limited

Tel: 01539 722002

Tel: 0207 601 6100

www.cropper.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEKLLFFZFFEFBE
Date   Source Headline
12th Mar 20243:06 pmRNSDirector/PDMR Shareholding
8th Mar 20242:25 pmRNSDirector/PDMR Shareholding
17th Jan 20247:00 amRNSTrading Update
12th Jan 20247:00 amRNSDirectorate Update
21st Dec 20233:33 pmRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSGrant of Awards under Long Term Incentive Plan
27th Nov 20237:00 amRNSBoard Appointment
24th Nov 20232:30 pmRNSDirectorate Change
9th Nov 20237:00 amRNSInterim Results
26th Oct 20237:00 amRNSNotice of Interim Results
26th Sep 20232:50 pmRNSResult of Annual General Meeting
26th Sep 20237:00 amRNSAGM Trading Update
4th Sep 20237:00 amRNSNotice of AGM
31st Aug 20237:00 amRNSInnovative production unit for green hydrogen
29th Aug 202312:43 pmRNSDividend Declaration
24th Aug 20237:00 amRNSFull Year Results
10th Aug 20237:00 amRNSNotice of Full Year Results
14th Jun 20237:00 amRNSDirectorship Change
7th Jun 20237:00 amRNSTFP HYDROGEN ANNOUNCES EXPANSION IN NORTH AMERICA
21st Apr 20235:18 pmRNSDirector/PDMR Shareholding
19th Apr 20237:00 amRNSTrading Update and Overview of Strategy
14th Feb 202312:00 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSDirector/PDMR Shareholding
31st Jan 20239:45 amRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSDirector/PDMR Shareholding
18th Nov 20229:48 amRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSHalf-year Report
31st Oct 20227:00 amRNSHalf Year Trading Update
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
12th Sep 202211:03 amRNSDirector/PDMR Shareholding
2nd Sep 20224:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20224:35 pmRNSPrice Monitoring Extension
26th Aug 20227:00 amRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSDirectorship Change
5th Aug 202211:45 amRNSDirector/PDMR Shareholding
27th Jul 202211:00 amRNSQ1 Trading Update and AGM Statement
19th Jul 20227:00 amRNSDirector/PDMR Shareholding
8th Jul 202210:34 amRNSDirector/PDMR Shareholding
7th Jul 20227:00 amRNSDirector/PDMR Shareholding
23rd Jun 202210:25 amRNSNotice of AGM and Annual Report & Accounts
21st Jun 20227:00 amRNSFinal Results
12th May 202212:01 pmRNSHolding(s) in Company
24th Mar 20227:00 amRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading Update
26th Jan 20222:30 pmRNSDirector/PDMR Shareholding
21st Jan 202212:15 pmRNSDirector/PDMR Shareholding
20th Jan 202210:30 amRNSDirectorate Change
12th Jan 20222:00 pmRNSCorrection to Director/PDMR Shareholding
12th Jan 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.